Evidence map›Paper›PMID 28934388›Full record

ArticleHuman molecular genetics2017

Loss of SLC25A46 causes neurodegeneration by affecting mitochondrial dynamics and energy production in mice.

Zhuo Li, Yanyan Peng, Robert B Hufnagel, Yueh-Chiang Hu, Chuntao Zhao, Luis F Queme, Zaza Khuchua, Ashley M Driver, Fei Dong, Q Richard Lu and 5 more

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Human molecular genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04594590 (A Natural History Study of Neurodegeneration and Optic Atrophy Caused by SLC25A46 Mutations in Pediatric and Adult Patients), which is not on this map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04594590 completednot on this mapstarted 2020, after this paper: background citation

A Natural History Study of Neurodegeneration and Optic Atrophy Caused by SLC25A46 Mutations in Pediatric and Adult Patients

Typeobservational_patient_registrySponsorState University of New York at BuffaloRan2020 to 2023Enrolled9ConditionsNeurodegenerative Disease, Hereditary, Mitochondrial Diseases, Optic AtrophyArmsMutation analysis
3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 67 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Gene therapy and mRNA drugs approach for mitochondrial OXPHOS deficiencies.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Review
  9. Review
  10. Identifying motor resilience proteins associated with motor decline in older adults.The journals of gerontology. Series A, Biological sciences and medical sciences · 2025
    Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 2 countries.

Zhuo LiDivision of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.
Yanyan PengDivision of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.
Robert B HufnagelDivision of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.
Yueh-Chiang HuDivision of Developmental Biology.
Chuntao ZhaoDivision of Experimental Hematology and Cancer Biology, Brain Tumor Center, Cancer and Blood Diseases Institute.
Luis F QuemeDivision of Anesthesia.
Zaza KhuchuaDivision of Molecular Cardiovascular Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.
Ashley M DriverDivision of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.
Fei DongDepartment of Ophthalmology, University of Cincinnati, Cincinnati, OH 45267, USA.
Q Richard LuDivision of Experimental Hematology and Cancer Biology, Brain Tumor Center, Cancer and Blood Diseases Institute.
Diana M LindquistDepartment of Radiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.
Michael P JankowskiDivision of Anesthesia.
Rolf W StottmannDivision of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.
Winston W Y KaoDepartment of Ophthalmology, University of Cincinnati, Cincinnati, OH 45267, USA.
Taosheng HuangDivision of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.
Cincinnati Children's Hospital Medical Center · USUniversity of Cincinnati · US

Funding

Molecular Mechanisms of Oligodendrocyte Differentiation and MyelinationR01NS072427 · NINDS · UT SOUTHWESTERN MEDICAL CENTER · PI LU, QING R · 2010 to 2018
$3.6M
Chromatin remodeling control of myelination and remyelinationR01NS075243 · NINDS · UT SOUTHWESTERN MEDICAL CENTER · PI LU, QING R · 2012 to 2018
$2.6M
Forward Genetic Analysis of Congenital Defects in Cortical Circuits and StructureR01NS085023 · NINDS · CINCINNATI CHILDRENS HOSP MED CTR · PI STOTTMANN, ROLF W · 2014 to 2018
$2.3M
Mechanisms of Muscle Afferent Sensitization after IschemiaR01AR064551 · NIAMS · CINCINNATI CHILDRENS HOSP MED CTR · PI JANKOWSKI, MICHAEL P · 2013 to 2017
$1.6M
Molecular and signaling mechanisms of peripheral nerve sheath tumorigenesisR37NS096359 · NINDS · CINCINNATI CHILDRENS HOSP MED CTR · PI LU, QING R · 2016 to 2018
$1.6M
SLC25A46 mutations cause optic atrophy, axonal neuropathy, and cerebellar neurodegenerationR01EY026609 · NEI · CINCINNATI CHILDRENS HOSP MED CTR · PI HUANG, TAOSHENG · 2016 to 2017
$780k
NEI NIH HHS R01 EY026609NIAMS NIH HHS R01 AR064551NINDS NIH HHS R01 NS072427NINDS NIH HHS R01 NS075243NINDS NIH HHS R01 NS085023NINDS NIH HHS R37 NS096359
6 · The paper itself

Abstract

Recently, we identified biallelic mutations of SLC25A46 in patients with multiple neuropathies. Functional studies revealed that SLC25A46 may play an important role in mitochondrial dynamics by mediating mitochondrial fission. However, the cellular basis and pathogenic mechanism of the SLC25A46-related neuropathies are not fully understood. Thus, we generated a Slc25a46 knock-out mouse model. Mice lacking SLC25A46 displayed severe ataxia, mainly caused by degeneration of Purkinje cells. Increased numbers of small, unmyelinated and degenerated optic nerves as well as loss of retinal ganglion cells indicated optic atrophy. Compound muscle action potentials in peripheral nerves showed peripheral neuropathy associated with degeneration and demyelination in axons. Mutant cerebellar neurons have large mitochondria, which exhibit abnormal distribution and transport. Biochemically mutant mice showed impaired electron transport chain activity and accumulated autophagy markers. Our results suggest that loss of SLC25A46 causes degeneration in neurons by affecting mitochondrial dynamics and energy production.

Indexed as

AnimalsAtaxiaFemaleHumansMaleMiceMice, KnockoutMitochondriaMitochondrial DynamicsMitochondrial ProteinsMutationPhosphate Transport ProteinsRetinal Ganglion CellsMitochondrial ProteinsPhosphate Transport ProteinsSLC25A46 protein, human

Identifiers

PMID28934388
PMCPMC6074941
OpenAlexW2733172056

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.